23-valent pneumococcal polysaccharide vaccine (Chengdu Institute of Biological Products)

23价肺炎球菌多糖疫苗（成都生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug Name23-valent pneumococcal polysaccharide vaccine (Chengdu Institute of Biological Products)

Drug Alias Name惠益康

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumonia, Bacterial

Global Approved IndicationsPneumonia, Bacterial

Approved Indications in ChinaPneumonia, Bacterial

Original Approved Country/TerritoryMainland China

Original Approved Date2006/04/24

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesChengdu Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChengdu Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsPneumonia, Bacterial

Inactive IndicationsN/A

Other Information

ATC CodeJ07AL01